VANCE trial marks milestone in t cell therapy for solid tumors

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

FDA issues guidance on stimulant use disorder drug development

The FDA draft guidance comprises considerations on subject safety and requirements for filing new drug applications. Credit: JHVEPhoto/Shutterstock.com. The US Food and Drug Administration (FDA)

October 5, 2023

U.S. Drops Virus-Hunting Program; Spicy Chip and Fatality; Lost Bladder Tumor

Note that some links may require registration or subscription. The United States Agency for International Development quietly dropped a flagship project for hunting viruses among

September 8, 2023

1 in 5 older Canadian adults with diabetes developed functional limitations during the pandemic

Researchers found that approximately 1 in 5 older Canadian adults with diabetes and no pre-pandemic functional limitations developed functional limitations for the first time during

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.